10-K Filing

Xenetic Biosciences, Inc. CIK: 1534525 FY 2018

Filing Information

Form Type	10-K
Accession Number	`0001683168-19-000840`
Period End Date	20181231
Filing Date	20190329
Fiscal Year	2018
Fiscal Period	FY
XBRL Instance	xbio-20181231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 58 Income Statement 22 Cash Flow Statement 46 Stockholders Equity 15

Balance Sheet 58 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	45.45M	shares	Point-in-time
Cash	`Cash`	$571.61K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.04M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	9.73M	shares	Point-in-time
Cash	`Cash`	$5.53M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$66.51K	USD	Point-in-time
Restricted cash	`RestrictedCash`	$66.51K	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	9.40M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	8.72M	shares	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$285.00K	USD	Point-in-time
Prepaid expenses and other	`PrepaidExpenseAndOtherAssetsCurrent`	$555.86K	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$5.88M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.19M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.85K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.96K	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Goodwill	`Goodwill`	$3.28M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Indefinite-lived intangible assets	`IndefiniteLivedIntangibleAssetsExcludingGoodwill`	$9.24M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$705.66K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$724.71K	USD	Point-in-time
Total assets	`Assets`	$19.16M	USD	Point-in-time
Total assets	`Assets`	$14.43M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$934.15K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$786.78K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$664.03K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.14M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$1.61K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$21.23K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.94M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Deferred tax liability	`DeferredTaxLiabilitiesNoncurrent`	$2.92M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.52M	USD	Point-in-time
Total liabilities	`Liabilities`	$4.86M	USD	Point-in-time
Commitments and contingent liabilities (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingent liabilities (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of December 31, 2018 and December 31, 2017; 9,727,774 and 9,041,426 shares issued as of December 31, 2018 and December 31, 2017, respectively; 9,403,889 and 8,717,541 shares outstanding as of December 31, 2018 and December 31, 2017, respectively	`CommonStockValue`	$9.73K	USD	Point-in-time
Common stock, $0.001 par value; 45,454,546 shares authorized as of December 31, 2018 and December 31, 2017; 9,727,774 and 9,041,426 shares issued as of December 31, 2018 and December 31, 2017, respectively; 9,403,889 and 8,717,541 shares outstanding as of December 31, 2018 and December 31, 2017, respectively	`CommonStockValue`	$9.04K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$165.25M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$168.16M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-145.93M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-153.23M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$253.73K	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Treasury stock	`TreasuryStockValue`	$5.28M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$9.91M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$16.17M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$14.30M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$14.43M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$19.16M	USD	Point-in-time

Income Statement 22 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`Revenues`	$7.58M	USD	Annual
Total revenues	`Revenues`	-	USD	Annual
Cost of research and development revenue	`OtherResearchAndDevelopmentExpense`	-	USD	Annual
Cost of research and development revenue	`OtherResearchAndDevelopmentExpense`	$156.12K	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$4.06M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.88M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$4.39M	USD	Annual
General and administrative	`GeneralAndAdministrativeExpense`	$6.94M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-7.28M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-3.57M	USD	Annual
Other expense	`OtherNonoperatingIncomeExpense`	$-24.55K	USD	Annual
Other expense	`OtherNonoperatingIncomeExpense`	$-24.64K	USD	Annual
Interest income (expense)	`InterestIncomeExpenseNet`	$-1.82K	USD	Annual
Interest income (expense)	`InterestIncomeExpenseNet`	$509.00	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-26.37K	USD	Annual
Total other expense	`NonoperatingIncomeExpense`	$-24.13K	USD	Annual
Net loss	`NetIncomeLoss`	$-7.30M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.60M	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.80	USD	Annual
Basic and diluted loss per share	`EarningsPerShareBasicAndDiluted`	$-0.41	USD	Annual
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.07M	shares	Annual
Weighted-average shares of common stock outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	8.67M	shares	Annual

Cash Flow Statement 46 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-7.30M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.60M	USD	Annual
Depreciation	`Depreciation`	$15.83K	USD	Annual
Depreciation	`Depreciation`	$23.78K	USD	Annual
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$15.44K	USD	Annual
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Share-based expense	`ShareBasedCompensation`	$1.35M	USD	Annual
Share-based expense	`ShareBasedCompensation`	$1.78M	USD	Annual
Warrant-based expense for services	`AdjustmentOfWarrantsGrantedForServices`	$-126.32K	USD	Annual
Warrant-based expense for services	`AdjustmentOfWarrantsGrantedForServices`	$10.21K	USD	Annual
Vendor share-based payments	`VendorShareBasedPayments`	$135.28K	USD	Annual
Vendor share-based payments	`VendorShareBasedPayments`	$69.71K	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-3.00M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$251.80K	USD	Annual
Prepaid expenses and other assets	`IncreaseDecreaseInAccountsAndOtherReceivables`	$-280.63K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-343.88K	USD	Annual
Accounts payable, accrued expenses and other liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-8.18K	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.49M	USD	Annual
Net cash (used in) provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-6.46M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$9.26K	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$22.50K	USD	Annual
Proceeds from sales of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-9.26K	USD	Annual
Net cash provided by (used in) investing activities	`NetCashProvidedByUsedInInvestingActivities`	$22.50K	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	Annual
Proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$1.48M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	-	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.48M	USD	Annual
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$1.48M	USD	Annual
Net change in cash and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-4.96M	USD	Annual
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.11M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$638.12K	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$5.60M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.11M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$1.93K	USD	Annual
Cash paid for interest	`InterestPaidNet`	$599.00	USD	Annual
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	$185.00	USD	Annual
Conversion of Series B preferred stock to common stock	`ConversionOfSeriesBPreferredStockToCommonStock`	$316.00	USD	Annual
Reclassification of common shares issuable to accounts payable	`ReclassificationOfCommonSharesIssuableToAccountsPayable`	$65.98K	USD	Annual
Reclassification of common shares issuable to accounts payable	`ReclassificationOfCommonSharesIssuableToAccountsPayable`	-	USD	Annual
Issuance of common stock for promissory note converted in 2016	`IssuanceOfCommonStockForPromissoryNoteConvertedIn2016`	-	USD	Annual
Issuance of common stock for promissory note converted in 2016	`IssuanceOfCommonStockForPromissoryNoteConvertedIn2016`	$125.00	USD	Annual

Stockholders Equity 15 line items

Line Item	Tag	Value	Unit	Period
Beginning balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$16.17M	USD	Point-in-time
Beginning balance, value	`StockholdersEquity`	$14.30M	USD	Point-in-time
Exercise of warrants, value	`StockIssuedDuringPeriodValueConversionOfUnits`	$1.48M	USD	Annual
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$1.78M	USD	Annual
Share-based expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition`	$1.35M	USD	Annual
Common stock awards to vendors	`CommonStockAwardsToVendors`	$69.30K	USD	Annual
Common stock awards to vendors	`CommonStockAwardsToVendors`	$69.71K	USD	Annual
Warrant expense	`AdjustmentOfWarrantsGrantedForServices`	$-126.32K	USD	Annual
Warrant expense	`AdjustmentOfWarrantsGrantedForServices`	$10.21K	USD	Annual
Net loss	`NetIncomeLoss`	$-7.30M	USD	Annual
Net loss	`NetIncomeLoss`	$-3.60M	USD	Annual
Ending balance, value	`StockholdersEquity`	$9.91M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$16.17M	USD	Point-in-time
Ending balance, value	`StockholdersEquity`	$14.30M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.